Literature DB >> 6359425

Methods for assessing hepatic encephalopathy.

S C Pappas, E A Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6359425     DOI： 10.1055/s-2008-1040782

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN： 0272-8087            Impact factor:   6.115


× No keyword cloud information.
  6 in total

Review 1.  Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy.

Authors:  J D Rothstein; M Olasmaa
Journal:  Neurochem Res       Date:  1990-02       Impact factor: 3.996

2.  Endozepine-4 levels are increased in hepatic coma.

Authors:  Giulia Malaguarnera; Marco Vacante; Filippo Drago; Gaetano Bertino; Massimo Motta; Maria Giordano; Michele Malaguarnera
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

3.  Improved quality of life after distal splenorenal shunt. A prospective comparison with side-to-side portacaval shunt.

Authors:  G Spina; R Santambrogio; E Opocher; F Galeotti; G Cucchiaro; M Strinna; G Pezzuoli
Journal:  Ann Surg       Date:  1988-07       Impact factor: 12.969

Review 4.  Methods for diagnosing hepatic encephalopathy in patients with cirrhosis: a multidimensional approach.

Authors:  Sara Montagnese; Piero Amodio; Marsha Y Morgan
Journal:  Metab Brain Dis       Date:  2004-12       Impact factor: 3.584

5.  Is portal-systemic shunt worthwhile in Child's class C cirrhosis? Long-term results of emergency shunt in 94 patients with bleeding varices.

Authors:  M J Orloff; M S Orloff; M Rambotti; B Girard
Journal:  Ann Surg       Date:  1992-09       Impact factor: 12.969

6.  Effects of L-acetylcarnitine on cirrhotic patients with hepatic coma: randomized double-blind, placebo-controlled trial.

Authors:  Mariano Malaguarnera; Giovanni Pistone; Marinella Astuto; Ignazio Vecchio; Rocco Raffaele; Emilia Lo Giudice; Liborio Rampello
Journal:  Dig Dis Sci       Date:  2006-11-01       Impact factor: 3.487
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.